| Original language | English |
|---|---|
| Pages (from-to) | 569-574 |
| Number of pages | 6 |
| Journal | Oncology Research - Anticancer drug design |
| Volume | 16 |
| Publication status | Published - 2008 |
Metabolites of the radiosensitizer nicotinamide are unlikely to contribute to the degree of emesis observed with the parent drug.
David Hirst
Research output: Contribution to journal › Article › peer-review